ADA in plasma for PEG-ADA (adenosine deaminase)

PEG-ADA is used as an enzyme replacement therapy for patients with ADA deficiency. Activity in plasma is measured as the conversion of adenosine to inosine.
Clinical details: 
Patients with adenosine deaminase (ADA) deficiency may be treated with an infusion of PEG-ADA. ADA activity in plasma, together with red cell dATP levels, are useful for monitoring efficacy of treatment.
Reference range: 

Please contact the laboratory to discuss

Sample type and Volume required: 
EDTA (purple top)
Turnaround time: 
1 week
Storage and transport: 
Store in fridge, ( don’t freeze) to laboratory within 7 days/1st class post
Purine Research Laboratory at St Thomas'
020 7188 1266
St Thomas’ Hospital
North Wing - 4th Floor
Westminster Bridge Road
London SE1 7EH
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 15/12/2015